GlassScriptPhysician profile
Suk K Choi
NPI 1821056839
$7,250.49
in general payments reported to CMS, 2019-2025
42 companies · $683 in 2025
The $683 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $838 · 2020: $655 · 2021: $1,429 · 2022: $1,119 · 2023: $1,102 · 2024: $1,424 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,209.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,264.01 | 2019-2025 | Ubrelvy, Vraylar |
| Pfizer INC. | $952.70 | 2019-2025 | |
| Novo Nordisk INC | $848.34 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $661.46 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $639.12 | 2019-2024 | Evenity, Prolia, Repatha |
| Abbott Laboratories | $434.56 | 2021-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $428.55 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $236.12 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $186.76 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $135.53 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $129.96 | 2019-2025 | Eliquis, Camzyos |
| Allergan, INC. | $126.33 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $117.85 | 2019 | |
| Sanofi-Aventis U.S. LLC | $107.22 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.33 | 2022-2025 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suk Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.